Association of interleukin-4 plasma levels with traumatic injury and clinical course

J. T. DiPiro, T. R. Howdieshell, J. K. Goddard, D. B. Callaway, R. G. Hamilton and A. R. Mansberger Jr
University of Georgia College of Pharmacy, Athens, USA.

OBJECTIVES: To determine if interleukin-4 (IL-4) could be detected in plasma of trauma patients and if IL-4 activity is associated with patterns of clinical events, complications, or outcomes. METHODS: A prospective case series conducted in a tertiary care referral center with a level I trauma center. One hundred patients admitted to the trauma intensive care unit for at least 3 days were included. Plasma concentrations of IL-4 and IgE were determined from admission to intensive care unit discharge. Data on clinical outcome were collected, including death, sepsis, severe sepsis, adult respiratory distress syndrome, pneumonia, and renal dysfunction. RESULTS: Interleukin-4 was detected in the plasma of 87 patients. Patients with an Injury Severity Score of greater than 25 had higher admission IL-4 levels (P = .03) and greater maximal IL-4 levels (P < .001). Admission hypotension (P = .04) and age 30 years or younger (P < .001) were also associated with higher admission IL-4 levels. Increases in IL-4 levels were significantly greater for patients in whom sepsis, severe sepsis, or pneumonia developed (P < .05). A low admission IL-4 level was associated with a greater incidence of nosocomial pneumonia (P < .001). Additional indirect evidence of IL-4 activation included increased plasma IgE levels. CONCLUSIONS: Anti-inflammatory cytokine mechanisms are activated after injury and are associated with the development of infectious complications (sepsis, severe sepsis, and pneumonia). Exogenous administration of interleukin-4 should be evaluated as an experimental therapeutic approach after trauma and associated sepsis.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cutting Edge: B Cell Receptor (BCR) Cross-Talk: The IL-4-Induced Alternate Pathway for BCR Signaling Operates in Parallel with the Classical Pathway, Is Sensitive to Rottlerin, and Depends on Lyn
Guo et al.
J. Immunol. 2007;178:4726-4730.
ABSTRACT | FULL TEXT  

Burn Wound Infections
Church et al.
Clin. Microbiol. Rev. 2006;19:403-434.
ABSTRACT | FULL TEXT  

B Cell Receptor (BCR) Cross-Talk: IL-4 Creates an Alternate Pathway for BCR-Induced ERK Activation That Is Phosphatidylinositol 3-Kinase Independent
Guo and Rothstein
J. Immunol. 2005;174:5375-5381.
ABSTRACT | FULL TEXT  

Jaks, STATs, Cytokines, and Sepsis
Scott et al.
CVI 2002;9:1153-1159.
FULL TEXT  

Hypertonicity rescues T cells from suppression by trauma-induced anti-inflammatory mediators
Loomis et al.
Am. J. Physiol. Cell Physiol. 2001;281:C840-C848.
ABSTRACT | FULL TEXT  

Interferon-{gamma} counteracts reduced endotoxin responsiveness of whole blood following trauma and cardiopulmonary bypass
Flohe et al.
Innate Immunity 2000;6:431-436.
ABSTRACT  

The Potential Pattern of Circulating Lymphocytes TH1/TH2 Is Not Altered After Multiple Injuries
Wick et al.
Arch Surg 2000;135:1309-1314.
ABSTRACT | FULL TEXT  

Tolerant B Lymphocytes Acquire Resistance to Fas-mediated Apoptosis after Treatment with Interleukin 4 but Not after Treatment with Specific Antigen Unless a Surface Immunoglobulin Threshold Is Exceeded
Foote et al.
JEM 1998;187:847-853.
ABSTRACT | FULL TEXT  

Inhibition of the Defense System Stimulating Interleukin-12 Interferon-gamma Pathway During Critical Illness
Ertel et al.
Blood 1997;89:1612-1620.
ABSTRACT | FULL TEXT